Financials
- Market Capitalization 1.86 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
—
ratio cours/chiffre d'affaires
4.65
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1971 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 26.79 USD | -3.35% | -7.91% | -27.59% | -9.92% | 1.93 B USD | ||
| 1991 | URGN UroGen Pharma Ltd. - Ordinary Shares | 38.26 USD | -0.05% | -6.00% | -11.54% | +101.37% | 1.87 B USD | ||
| 2000 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 21.00 USD | -5.53% | -3.63% | -26.52% | -47.98% | 1.86 B USD | ||
| 2017 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 30.21 USD | -1.98% | -3.70% | -9.09% | -30.38% | 1.80 B USD |